• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定价、监管与竞争力。日本制药行业给美国的启示。

Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.

作者信息

Thomas L G

机构信息

School of Business, Emory University, Atlanta, Georgia, USA.

出版信息

Pharmacoeconomics. 1994;6 Suppl 1:67-70. doi: 10.2165/00019053-199400061-00016.

DOI:10.2165/00019053-199400061-00016
PMID:10155588
Abstract

This paper examines the nature of Japanese government regulation of pharmaceutical prices, and the impact of that regulation on the competitive performance of the Japanese industry. Possible implications for the reintroduction of pharmaceutical price controls in the US are also considered.

摘要

本文探讨了日本政府对药品价格的监管性质,以及该监管对日本制药行业竞争表现的影响。同时也考虑了对美国重新实施药品价格管制可能产生的影响。

相似文献

1
Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.定价、监管与竞争力。日本制药行业给美国的启示。
Pharmacoeconomics. 1994;6 Suppl 1:67-70. doi: 10.2165/00019053-199400061-00016.
2
Examining the link between price regulation and pharmaceutical R&D investment.审视价格监管与制药研发投资之间的联系。
Health Econ. 2005 Jan;14(1):1-16. doi: 10.1002/hec.897.
3
Pharmaceutical policy in the Netherlands: from price regulation towards managed competition.荷兰的药品政策:从价格监管走向管理式竞争。
Adv Health Econ Health Serv Res. 2010;22:53-76. doi: 10.1108/s0731-2199(2010)0000022006.
4
Pharmaceutical pricing, price controls, and their effects on pharmaceutical sales and research and development expenditures in the European Union.欧盟的药品定价、价格管制及其对药品销售以及研发支出的影响。
Clin Ther. 2004 Aug;26(8):1327-40; discussion 1326. doi: 10.1016/s0149-2918(04)80209-1.
5
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.制药行业中的反垄断、市场独占权与透明度
JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478.
6
Price regulation in the pharmaceutical industry: prescription or placebo?制药行业的价格监管:是良方还是安慰剂?
J Health Econ. 1995 Dec;14(5):551-65. doi: 10.1016/0167-6296(95)00022-4.
7
Drug Reimbursement Regulation in 6 Peer Countries.6 个对标国家的药品报销政策
JAMA Intern Med. 2020 Nov 1;180(11):1510-1517. doi: 10.1001/jamainternmed.2020.4793.
8
What price competitiveness in the drugs industry?制药行业的价格竞争力体现在何处?
Lancet. 2003 Jul 26;362(9380):257. doi: 10.1016/s0140-6736(03)14000-7.
9
Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance.城镇职工基本医疗保险下规制竞争对中国药品市场定价的影响
Expert Rev Pharmacoecon Outcomes Res. 2017 Jun;17(3):311-320. doi: 10.1080/14737167.2017.1251318. Epub 2016 Nov 8.
10
Can price and regulatory controls replace free market competition in the drug industry?价格和监管控制能否取代制药行业的自由市场竞争?
Healthspan. 1993 Nov;10(10):30-2.

引用本文的文献

1
Why medical care costs in Japan have increased despite declining prices for pharmaceuticals.为何在药品价格下降的情况下日本的医疗费用仍在上涨。
Pharmacoeconomics. 1998;14 Suppl 1:97-105. doi: 10.2165/00019053-199814001-00012.